Literature DB >> 19878874

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Dawang Zhou1, Claudius Conrad, Fan Xia, Ji-Sun Park, Bernhard Payer, Yi Yin, Gregory Y Lauwers, Wolfgang Thasler, Jeannie T Lee, Joseph Avruch, Nabeel Bardeesy.   

Abstract

Hippo-Lats-Yorkie signaling regulates tissue overgrowth and tumorigenesis in Drosophila. We show that the Mst1 and Mst2 protein kinases, the mammalian Hippo orthologs, are cleaved and constitutively activated in the mouse liver. Combined Mst1/2 deficiency in the liver results in loss of inhibitory Ser127 phosphorylation of the Yorkie ortholog, Yap1, massive overgrowth, and hepatocellular carcinoma (HCC). Reexpression of Mst1 in HCC-derived cell lines promotes Yap1 Ser127 phosphorylation and inactivation and abrogates their tumorigenicity. Notably, Mst1/2 inactivates Yap1 in liver through an intermediary kinase distinct from Lats1/2. Approximately 30% of human HCCs show low Yap1(Ser127) phosphorylation and a majority exhibit loss of cleaved, activated Mst1. Mst1/2 inhibition of Yap1 is an important pathway for tumor suppression in liver relevant to human HCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878874      PMCID: PMC3023165          DOI: 10.1016/j.ccr.2009.09.026

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  43 in total

1.  Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation.

Authors:  S Ura; N Masuyama; J D Graves; Y Gotoh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  The Ste20 group kinases as regulators of MAP kinase cascades.

Authors:  I Dan; N M Watanabe; A Kusumi
Journal:  Trends Cell Biol       Date:  2001-05       Impact factor: 20.808

3.  MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation.

Authors:  K K Lee; T Ohyama; N Yajima; S Tsubuki; S Yonehara
Journal:  J Biol Chem       Date:  2001-03-07       Impact factor: 5.157

4.  Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes.

Authors:  Koko Katagiri; Tomoya Katakai; Yukihiko Ebisuno; Yoshihiro Ueda; Takaharu Okada; Tatsuo Kinashi
Journal:  EMBO J       Date:  2009-04-02       Impact factor: 11.598

5.  Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region.

Authors:  Ruchi Anand; Ah-Young Kim; Michael Brent; Ronen Marmorstein
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

6.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Authors:  H Morrison; L S Sherman; J Legg; F Banine; C Isacke; C A Haipek; D H Gutmann; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

7.  Caspase 3 activity is required for skeletal muscle differentiation.

Authors:  Pasan Fernando; John F Kelly; Kim Balazsi; Ruth S Slack; Lynn A Megeney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

Review 8.  Rassf family of tumor suppressor polypeptides.

Authors:  Joseph Avruch; Ramnik Xavier; Nabeel Bardeesy; Xian-Feng Zhang; Maria Praskova; Dawang Zhou; Fan Xia
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

9.  The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.

Authors:  Kieran F Harvey; Cathie M Pfleger; Iswar K Hariharan
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

10.  hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.

Authors:  Shian Wu; Jianbin Huang; Jixin Dong; Duojia Pan
Journal:  Cell       Date:  2003-08-22       Impact factor: 41.582

View more
  432 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  DNA methylation biomarkers for lung cancer.

Authors:  Tibor A Rauch; Zunde Wang; Xiwei Wu; Kemp H Kernstine; Arthur D Riggs; Gerd P Pfeifer
Journal:  Tumour Biol       Date:  2011-12-06

3.  MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.

Authors:  Bekir Cinar; Filiz Kisaayak Collak; Delia Lopez; Seckin Akgul; Nishit K Mukhopadhyay; Murat Kilicarslan; Daniel G Gioeli; Michael R Freeman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

4.  A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.

Authors:  Masamichi Imajo; Koichi Miyatake; Akira Iimura; Atsumu Miyamoto; Eisuke Nishida
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

5.  Dimerization and cytoplasmic localization regulate Hippo kinase signaling activity in organ size control.

Authors:  Yunyun Jin; Liang Dong; Yi Lu; Wenqing Wu; Qian Hao; Zhaocai Zhou; Jin Jiang; Yun Zhao; Lei Zhang
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

6.  Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.

Authors:  Yun-Yong Park; Bo Hwa Sohn; Randy L Johnson; Myoung-Hee Kang; Sang Bae Kim; Jae-Jun Shim; Lingegowda S Mangala; Ji Hoon Kim; Jeong Eun Yoo; Cristian Rodriguez-Aguayo; Sunila Pradeep; Jun Eul Hwang; Hee-Jin Jang; Hyun-Sung Lee; Rajesha Rupaimoole; Gabriel Lopez-Berestein; Woojin Jeong; Inn Sun Park; Young Nyun Park; Anil K Sood; Gordon B Mills; Ju-Seog Lee
Journal:  Hepatology       Date:  2015-11-26       Impact factor: 17.425

7.  Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

Authors:  Ana Sebio; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

8.  The tumor suppressor Mst1 promotes changes in the cellular redox state by phosphorylation and inactivation of peroxiredoxin-1 protein.

Authors:  Sonali Jalan Rawat; Caretha L Creasy; Jeffrey R Peterson; Jonathan Chernoff
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

9.  A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Authors:  Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Hepat Oncol       Date:  2014-01-01

10.  HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.

Authors:  Celine Hernandez; Peter Huebener; Jean-Philippe Pradere; Daniel J Antoine; Richard A Friedman; Robert F Schwabe
Journal:  J Clin Invest       Date:  2018-05-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.